journal article·2021-04Open access

Smart Self‐Assembly Amphiphilic Cyclopeptide‐Dye for Near‐Infrared Window‐II Imaging

Hao Chen, Kangquan Shou, Si Chen, Chunrong Qu, Zhiming Wang, Lei Jiang, Mark Zhu, Bingbing Ding, Kun Qian, Aiyan Ji, Hongyue Lou, Ling Tong, Alexander Hsu, Yuebing Wang, Dean W. Felsher, Zhenhua Hu, Jie Tian, Zhen Cheng

Advanced Materials· Volume 33· Issue 16

Abstract

Abstract Development of novel nanomaterials for disease theranostics represents an important direction in chemistry and precision medicine. Fluorescent molecular probes in the second near‐infrared window (NIR‐II, 1000–1700 nm) show high promise because of their exceptional high detection sensitivity, resolution, and deep imaging depth. Here, a sharp pH‐sensitive self‐assembling cyclopeptide‐dye, SIMM1000, as a smart nanoprobe for NIR‐II imaging of diseases in living animals, is reported. This small molecule assembled nanoprobe exhibits smart properties by responding to a sharp decrease of pH in the tumor microenvironment (pH 7.0 to 6.8), aggregating from small nanoprobe (80 nm at pH 7.0) into large nanoparticles (>500 nm at pH 6.8) with ≈20–30 times enhanced fluorescence compared with the non‐self‐assembled CH‐4T. It yields micrometer‐scale resolution in blood vessel imaging and high contrast and resolution in bone and tumor imaging in mice. Because of its self‐aggregation in acidic tumor microenvironments in situ, SIMM1000 exhibits high tumor accumulation and extremely long tumor retention (>19 days), while being excretable from normal tissues and safe. This smart self‐assembling small molecule strategy can shift the paradigm of designing new nanomaterials for molecular imaging and drug development.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Molecular Imaging Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China

Molecular Imaging Program at Stanford (MIPS) Bio‐X Program and Department of Radiology Canary Center at Stanford for Cancer Early Detection Stanford University Stanford CA 94305–5344 USA

Division of Oncology Departments of Medicine and Pathology Stanford University School of Medicine Stanford CA 94305 USA

CAS Key Laboratory of Molecular Imaging The State Key Laboratory of Management and Control for Complex Systems Beijing Key Laboratory of Molecular Imaging Institute of Automation Chinese Academy of Sciences Beijing 100190 China

Funding

Office of Science · Bernard Osher Foundation · U.S. Department of Energy · National Basic Research Program of China · National Natural Science Foundation of China

References (44)

Show source-provided references
1. 10.1038/nmat381910.1038/nmat3819 ↗
2. 10.1016/j.critrevonc.2013.06.01010.1016/j.critrevonc.2013.06.010 ↗
3. 10.1186/1475-2867-13-8910.1186/1475-2867-13-89 ↗
4. 10.1083/jcb.101.6.221010.1083/jcb.101.6.2210 ↗
5. 10.1038/s41551-016-000610.1038/s41551-016-0006 ↗
6. 10.1016/j.transproceed.2004.09.00110.1016/j.transproceed.2004.09.001 ↗
7. 10.1016/B978-0-12-411638-2.00005-710.1016/B978-0-12-411638-2.00005-7 ↗
8. 10.1039/C9SC06567A10.1039/C9SC06567A ↗
9. 10.1039/C9CC09865H10.1039/C9CC09865H ↗
10. 10.1038/nmat447610.1038/nmat4476 ↗
11. 10.1021/acs.jmedchem.8b0168210.1021/acs.jmedchem.8b01682 ↗
12. 10.1038/ncomms1526910.1038/ncomms15269 ↗
13. 10.1002/adma.20160549710.1002/adma.201605497 ↗
14. 10.1021/acsnano.7b0596610.1021/acsnano.7b05966 ↗
15. 10.1039/c1sm05789h10.1039/c1sm05789h ↗
16. 10.1021/acs.bioconjchem.8b0066910.1021/acs.bioconjchem.8b00669 ↗
17. 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T ↗
18. 10.1021/ja960372110.1021/ja9603721 ↗
19. 10.2144/00011209110.2144/000112091 ↗
20. 10.1002/adma.20170685610.1002/adma.201706856 ↗
21. 10.1039/C8SC04363A10.1039/C8SC04363A ↗
22. Gao S. · Nat. Commun. · 2019 · 10
23. 10.1038/s41467-019-13993-710.1038/s41467-019-13993-7 ↗
24. 10.1002/adma.20190736510.1002/adma.201907365 ↗
25. 10.1073/pnas.171891711510.1073/pnas.1718917115 ↗
26. 10.1371/journal.pone.018756310.1371/journal.pone.0187563 ↗
27. 10.1002/jcp.2235610.1002/jcp.22356 ↗
28. Tome Y. · Anticancer Res. · 2013 · 33 · 3623
29. 10.1158/1078-0432.CCR-12-037410.1158/1078-0432.CCR-12-0374 ↗
30. 10.1242/jcs.112.22.398510.1242/jcs.112.22.3985 ↗
31. 10.1002/anie.20140493010.1002/anie.201404930 ↗
32. 10.1038/nm.261710.1038/nm.2617 ↗
33. 10.1016/j.transproceed.2013.11.12910.1016/j.transproceed.2013.11.129 ↗
34. 10.4254/wjh.v8.i7.35510.4254/wjh.v8.i7.355 ↗
35. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
36. 10.1021/acs.bioconjchem.6b0043710.1021/acs.bioconjchem.6b00437 ↗
37. Kufe D. W. · 2003
38. Tannock I. F. · Cancer Res. · 1989 · 49 · 4373
39. 10.1002/cmmi.146410.1002/cmmi.1464 ↗
40. 10.1158/0008-5472.CAN-04-195610.1158/0008-5472.CAN-04-1956 ↗
41. 10.1117/1.JBO.21.8.08090110.1117/1.JBO.21.8.080901 ↗
42. 10.1038/nphoton.2009.3210.1038/nphoton.2009.32 ↗
43. 10.1016/S0360-3016(98)00510-010.1016/S0360-3016(98)00510-0 ↗
44. 10.1007/s11426-019-9685-610.1007/s11426-019-9685-6 ↗